Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) (Q35620372)

From Wikidata
Revision as of 19:15, 7 April 2018 by Fatameh sister bot (talk | contribs) (‎Updated Item: Removing the trailing dot from the title)
Jump to navigation Jump to search
scientific article published on 28 February 2011
Language Label Description Also known as
English
Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)
scientific article published on 28 February 2011

    Statements

    title
    Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    21356079
    retrieved
    9 August 2017

    Identifiers

     
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q35620372&oldid=662623357"